$KYMR Kymera Therapeutics, Inc. Insider Trading Week 15/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kymera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kymera Therapeutics, Inc. in week 15/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 15,000 | 31,200 | 157,424 | |
| Apr 13 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 15,000 | 31,200 | 391,199 | 376.2 K to 391.2 K (+3.99 %) |
| Apr 13 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 7,000 | 14,560 | 229,899 | |
| Apr 13 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 7,000 | 14,560 | 7,000 | 0 to 7 K |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 15,267 | 31,755 | 244,725 | |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 22,794 | 47,412 | 259,992 | |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 9,939 | 20,673 | 282,786 | |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 33.32 | 4,905 | 163,414 | 376,199 | 381.1 K to 376.2 K (-1.29 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 32.29 | 10,362 | 334,566 | 381,104 | 391.5 K to 381.1 K (-2.65 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 15,267 | 31,755 | 391,466 | 376.2 K to 391.5 K (+4.06 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 34.19 | 3,742 | 127,923 | 376,199 | 379.9 K to 376.2 K (-0.98 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 33.58 | 19,052 | 639,827 | 379,941 | 399 K to 379.9 K (-4.78 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 22,794 | 47,412 | 398,993 | 376.2 K to 399 K (+6.06 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 35.62 | 2,323 | 82,748 | 376,199 | 378.5 K to 376.2 K (-0.61 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 34.81 | 7,616 | 265,084 | 378,522 | 386.1 K to 378.5 K (-1.97 %) |
| Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 9,939 | 20,673 | 386,138 | 376.2 K to 386.1 K (+2.64 %) |